Tandem Diabetes Care, Inc. (NASDAQ:TNDM) reported better-than-expected fourth-quarter financial results on Thursday.Tandem Diabetes Care reported quarterly losses of 1 cent per share which beat the analyst consensus estimate of losses of 8 cents per share. The company reported quarterly sales of $290.400 million which beat the analyst consensus estimate of $277.029 million.Tandem Diabetes Care said it sees FY2026 sales of $1.065 billion to $1.085 billion, versus market estimates of $1.103 billion.“2025 was ...

Core Insights - CVS Health Foundation has granted $2.6 million to the American Diabetes Association (ADA) to expand its maternal health initiative in New York City, building on 18 months of successful outcomes in improving gestational diabetes screening and care coordination [1][2] Group 1: Program Expansion - The initiative will expand to two additional communities in New York City, aiming to support more families during the prenatal and postpartum journey [6] - The program will enhance electronic medical records (EMR) dashboards to streamline referrals among healthcare providers, ensuring seamless care transitions [6] - Increased access to advanced diabetes technology, including continuous glucose monitoring (CGM), will be provided, along with medically tailored meals to address food insecurity [6] Group 2: Health Statistics and Impact - At Wyckoff Heights Medical Center, over 20% of patients have diabetes, with 56% having an A1C above 9%, indicating poor blood sugar control [3] - Gestational diabetes mellitus (GDM) affects up to 9% of pregnancies nationwide, with rates in New York City rising from 6% in 2016 to 8.3% in 2021 [8] - In Bushwick, Brooklyn, 19% of adults have diabetes, and avoidable hospitalizations are 70% higher than the city average [8] Group 3: Patient Support and Education - The program provides multilingual education for patients and community health workers to support healthy pregnancies and postpartum care [7] - Patients like C.H., who was diagnosed with gestational diabetes, have benefited from nutritional workshops and support from community health workers, leading to improved confidence in managing their health [9][10] Group 4: Organizational Background - The CVS Health Foundation focuses on addressing health challenges through collaboration with nonprofit organizations, with a commitment to enhancing health outcomes in various areas, including maternal health and chronic conditions like diabetes [10] - The American Diabetes Association (ADA) is a leading health organization dedicated to fighting diabetes and supporting individuals affected by the condition, celebrating 85 years of advocacy and program development [11]

Core Insights - embecta Corp. has expanded its partnership with Direct Relief to enhance access to diabetes care for underserved communities in the U.S. and globally [1][2][3] Company Overview - embecta was spun off from Becton, Dickinson and Company in 2022, acquiring BD-branded pen needles and insulin syringes [2] - The company has updated its packaging in North America from the BD brand to the embecta brand in 2025 [2] - Since becoming independent, embecta has focused on empowering individuals with diabetes and ensuring access to necessary supplies [3] Partnership Details - embecta has donated approximately 15 million units of pen needles and insulin syringes to Direct Relief, marking its largest humanitarian partnership since independence [2] - The partnership aims to provide essential diabetes management supplies to uninsured and low-income patients through Direct Relief's Safety Net Support Program [4][5] - Direct Relief collaborates with over 1,600 community health centers and clinics, serving more than 36 million patients, including a significant portion of the uninsured population in the U.S. [4] Global Impact - The partnership supports Direct Relief's Life for a Child program, which provides diabetes care to over 53,000 children and young people in 45 countries [6] - embecta's donations also support diabetes care in crisis-affected regions, including a recent donation of 2.7 million insulin needles and syringes for a campaign in Sudan [8][7] Educational Initiatives - embecta supports diabetes education camps through Direct Relief, providing essential supplies to help children and young adults learn diabetes management skills [10] Emergency Response - The partnership includes emergency response capabilities, with a recent grant of $25,000 from embecta to support disaster relief efforts in Texas [11] Industry Context - Over 537 million people globally live with diabetes, with projections reaching 783 million by 2045; in the U.S., approximately 38 million individuals are affected [12] - Access to affordable diabetes care remains a critical challenge, particularly for uninsured and underinsured populations [12]